CTOR

Citius Oncology
CTOR

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $34.3M invested in Citius Oncology in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.08M
2
+$4.06M
3
+$3.93M
4
WAM
Weiss Asset Management
Massachusetts
+$3.56M
5
WCMNY
Westchester Capital Management (New York)
New York
+$3.05M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.08M
2
$4.06M
3
$3.93M
4
$3.56M
5
$3.05M
6
$3.04M
7
$2.68M
8
$1.92M
9
$1.52M
10
$1.52M
11
$1.37M
12
$1.27M
13
$762K
14
$508K
15
$4.06K